Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790020 | Urologic Oncology: Seminars and Original Investigations | 2018 | 16 Pages |
Abstract
The current rationale supports the importance of moving the CTC field beyond proof of concept studies toward molecular-based solutions capable of improving disease management. The road has been paved for identification of highly specific CTC biomarkers and novel targeted approaches, foreseeing successful clinical applications.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rita M.Sc., Janine B.Sc., Andreia M.Sc., Sofia M.Sc., LuÃs Ph.D., Lúcio Lara M.D., Ph.D., José Alexandre Ph.D.,